Elimination of DHHC3 in xenograft models reduces primary tumor growth and lung metastasis while increasing oxidative stress, cellular senescence, and recruitment of anti-tumor immune cells (e.g., macrophages, NK cells). The gene discussed is ZDHHC3; the disease is neoplasm.